Company VolitionRX Ltd OTC Bulletin Board

Equities

VNRX

US9286611077

Biotechnology & Medical Research

Business Summary

Sales per Business

Sales per region

Managers

Members of the board

Share class

Shareholders

Company contact information

Sector

Sales per Business

Sector Bio Diagnostics & Testing

Inactive Instrument

VolitionRx Limited is a multi-national epigenetics company focused on advancing the science of epigenetics. The Company is dedicated to saving lives and improving outcomes for people and animals with life-altering diseases through earlier detection, as well as disease and treatment monitoring. Through its subsidiaries, it is developing and commercializing blood tests to help diagnose and monitor a range of diseases, including cancers and diseases associated with NETosis, such as sepsis. Its key pillars are Nu.Q Vet, Nu.Q NETs, Nu.Q Discover, Nu.Q Cancer and Capture-PCR. The Nu.Q Vet Cancer Test is commercially available as a cancer screening test in dogs. Nu.Q NETs is monitoring the immune system to save lives. Nu.Q Discover is a complete solution to profiling nucleosomes. Nu.Q Cancer monitoring disease progression, response to treatment and minimal residual disease. Capture-PCRTM is isolating and capturing circulating tumor-derived DNA from plasma samples for early cancer detection.

USD in Million	Weight	2023	Weight	Delta
Blood Tests 77.2 %	68.9 %	1	77.2 %	+183.64%
Service 22.6 %	30.2 %	0	22.6 %	+89.73%
Royalty 0.2 %	1.0 %	0	0.2 %	-52.97%

USD in Million	2022	Weight	2023	Weight	Delta
United States 100.0 %	0	100.0 %	1	100.0 %	+153.04%

Managers	Title	Age	Since
Cameron Reynolds CEO	Chief Executive Officer	53	11-10-05
Terig Hughes DFI	Director of Finance/CFO	54	21-01-31
Gaetan Michel COO	Chief Operating Officer	51	21-01-31
Mark Eccleston CTO	Chief Tech/Sci/R&D Officer	42	-
Jacob Micallef CTO	Chief Tech/Sci/R&D Officer	67	14-12-31
Louise Batchelor IRO	Public Communications Contact	-	16-04-13
Terry Kelly PRN	Corporate Officer/Principal	-	20-02-29
Gael Forterre PRN	Corporate Officer/Principal	43	21-01-31
Rodney Rootsaert SEC	Corporate Secretary	52	11-10-05
Nick Plummer LAW	General Counsel	-	21-10-31

Members of the board	Title	Age	Since
Cameron Reynolds CEO	Chief Executive Officer	53	11-10-05
Guy Innes CHM	Chairman	67	-
Alan Colman BRD	Director/Board Member	75	11-10-05
Phillip Barnes BRD	Director/Board Member	62	19-10-08
Kim Nguyen BRD	Director/Board Member	47	21-03-24
Mickie Henshall BRD	Director/Board Member	52	22-08-14

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	82,928,314	63,712,224 ( 76.83 %)	0	76.83 %

Name	Equities	%	Valuation
Cotterford Co. Ltd. 14.48 %	12,005,332	14.48 %	7 M $
Lagoda Investment Management LP 6.118 %	5,073,242	6.118 %	3 M $
Guy Innes 2.737 %	2,269,697	2.737 %	1 M $
Martin Faulkes 2.349 %	1,947,682	2.349 %	1 M $
Cameron Reynolds 2.266 %	1,878,926	2.266 %	1 M $
Concord International, Inc. 1.215 %	1,007,718	1.215 %	609 669 $
Vanguard Global Advisers LLC 0.7671 %	636,167	0.7671 %	384 881 $
Geode Capital Management LLC 0.7445 %	617,366	0.7445 %	373 506 $
BlackRock Institutional Trust Co. NA 0.6818 %	565,408	0.6818 %	342 072 $
Jacob Micallef 0.4731 %	392,337	0.4731 %	237 364 $

VolitionRX Ltd.

1489 West Warm Springs Road Suite 110

89014, Henderson

http://www.volition.com

Healthcare

Pharmaceuticals & Medical Research

Biotechnology & Medical Research

Biotechnology & Medical Research

Bio Diagnostics & Testing

	1st Jan change	Capi.
EXACT SCIENCES CORPORATION	-39.39%	8.36B
GUARDANT HEALTH, INC.	+10.79%	3.38B
IOVANCE BIOTHERAPEUTICS, INC.	+3.81%	2.18B
BGI GENOMICS CO., LTD.	-25.96%	1.82B
VERACYTE, INC.	-17.96%	1.64B
MARAVAI LIFESCIENCES HOLDINGS, INC.	+31.30%	1.03B
CAREDX, INC	+31.42%	752M
SEEGENE, INC.	-12.01%	689M
ADAPTIVE BIOTECHNOLOGIES CORPORATION	-20.61%	516M

Bio Diagnostics & Testing